Araştırma Makalesi

The effect of SARS-CoV2 disease on fatigue, sleep, physical activity, and kinesiophobia in patients with systemic hypertension

Cilt: 62 Sayı: 3 18 Eylül 2023
PDF İndir
TR EN

The effect of SARS-CoV2 disease on fatigue, sleep, physical activity, and kinesiophobia in patients with systemic hypertension

Abstract

Aim: No other studies investigated fatigue, sleep, physical activity, and kinesiophobia in individuals with hypertension. The present study aimed to investigate the effect of SARS-CoV2 disease on fatigue, sleep, physical activity, and kinesiophobia in individuals with systemic hypertension. Materials and Methods: A prospective cross-sectional study was carried out with a total of 99 people with hypertension, including 53 of them with SARS-CoV2 disease history. Patients were evaluated with the “International Physical Activity Questionnaire Short Form (IPAQ-SF), Fatigue Severity Scale (FSS), Tampa Scale of Kinesiophobia for Heart (TSK Heart), and Pittsburgh Sleep Quality Index (PSQI)”. Results: People with hypertension in the SARS-CoV2 positive group had a significantly higher moderate PA sub score of the IPAQ (Metabolic Equivalent of Task (MET) minutes per week) (p=0.014). Besides, the FSS scores of SARS-CoV2 positive patients were significantly higher (p=0.019). FSS was moderately associated with TSK Heart and PSQI (r1=0.575, r2=0.654, respectively). TSK Heart was moderately correlated with moderate PA sub score of the IPAQ and IPAQ-Total score (r1=-0.394, r2=-0.436, respectively). Conclusion: SARS-CoV2 was found to be responsible for fatigue in people with hypertension. Kinesiophobia was related with both total and moderate PA in COVID-19 positive hypertension patients. Besides, fatigue was correlated with kinesiophobia and sleep quality.

Keywords

Destekleyen Kurum

Yok

Kaynakça

  1. Wadhera RK, Shen C, Gondi S, Chen S, Kazi DS, Yeh RW. Cardiovascular deaths during the COVID-19 pandemic in the United States. Journal of the J Am Coll Cardiol 2021;77(2):159-69.
  2. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054-62.
  3. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180(7):934-43.
  4. Bozkurt B, Kovacs R, Harrington B. Joint HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19. J Card Fail 2020;26(5):370.
  5. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020;94(1):91-5.
  6. Drager LF, Pio-Abreu A, Lopes RD, Bortolotto LA. Is hypertension a real risk factor for poor prognosis in the COVID-19 pandemic? Curr Hypertens Rep 2020;22(6):1-6.
  7. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet 2020;8(5):475-81.
  8. Zekavat SM, Honigberg M, Pirruccello JP, et al. Elevated blood pressure increases pneumonia risk: epidemiological association and mendelian randomization in the UK Biobank. Med 2021;2(2):137-48.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

18 Eylül 2023

Gönderilme Tarihi

3 Eylül 2022

Kabul Tarihi

14 Aralık 2022

Yayımlandığı Sayı

Yıl 2023 Cilt: 62 Sayı: 3

Kaynak Göster

Vancouver
1.Fatih Özden, Zahide Yuvakgil, Mehmet Özkeskin, Zeynep Altın. The effect of SARS-CoV2 disease on fatigue, sleep, physical activity, and kinesiophobia in patients with systemic hypertension. ETD. 01 Eylül 2023;62(3):346-54. doi:10.19161/etd.1360285

Ege Tıp Dergisi, makalelerin Atıf-Gayri Ticari-Aynı Lisansla Paylaş 4.0 Uluslararası (CC BY-NC-SA 4.0) lisansına uygun bir şekilde paylaşılmasına izin verir.